Nov 12 (Reuters) - Alkermes ( ALKS ) said on Wednesday
its experimental narcolepsy drug met the main goals in a
mid-stage study.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Anil
D'Silva)